Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-10 @ 9:38 AM
Study NCT ID:
NCT02273167
Status:
COMPLETED
Last Update Posted:
2018-05-15
First Post:
2014-10-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.
Sponsor:
Norgine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-16
First Submit QC Date:
None
Study First Post Date:
2014-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-19
Results First Submit QC Date:
None
Results First Post Date:
2017-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-12
Last Update Post Date:
2018-05-15
Last Update Post Date Type:
ACTUAL